: A significant portion of Green’s work involves the study of HTLV-1 , the first discovered human retrovirus. His research delves into how viral proteins like Tax and HBZ manipulate host cell signaling to drive leukemia and inflammatory diseases.
: Identifying specific viral mechanisms that can be inhibited to treat or prevent HTLV-associated adult T-cell leukemia/lymphoma (ATL). The "Academic Shorthand" Context Green2-4
: The "2-4" designation in research abstracts often links him to multiple powerhouse institutions at Ohio State—specifically the Center for Retrovirus Research (2) and the Comprehensive Cancer Center (4) . This cross-disciplinary approach allows his team to bridge the gap between basic virology and clinical oncology. Key Focus Areas : : A significant portion of Green’s work involves